Aclarion (ACON) News Today $0.32 +0.02 (+6.58%) (As of 07/26/2024 ET) Add Compare Share Share HeadlinesStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 October 2021 September 2021 August 2021 Time Period July 26 at 3:08 AM | americanbankingnews.comAnalyzing Personalis (NASDAQ:PSNL) & Aclarion (NASDAQ:ACON)July 26 at 2:16 AM | americanbankingnews.comAclarion, Inc. (NASDAQ:ACON) Sees Significant Drop in Short InterestJuly 17, 2024 | americanbankingnews.comAclarion, Inc. (NASDAQ:ACON) Short Interest Down 6.1% in JuneJuly 9, 2024 | globenewswire.comAclarion Achieves Milestone With Key Second Payer Coverage of Nociscan by Aviva Throughout Greater London, UKJune 26, 2024 | globenewswire.comAclarion Announces Initial Payer Coverage of Nociscan by AXA Throughout Greater London, UKJune 25, 2024 | globenewswire.comAclarion Expands Commercial Engagement With The London Clinic to Grow Access to Nociscan Throughout Greater LondonMay 16, 2024 | msn.comACON Stock Earnings: Aclarion Reported Results for Q1 2024April 25, 2024 | globenewswire.comAclarion's Nociscan Solution to Play Key Role in Groundbreaking LIFEHAB Trial Evaluating the Diagnosis and Treatment of Chronic Low Back PainApril 23, 2024 | finance.yahoo.comAclarion to Present at the Planet MicroCap Showcase: VEGAS 2024 on Wednesday, May 1, 2024 & 1x1 Meetings on Thursday, May 2, 2024April 2, 2024 | benzinga.comWhy Stryve Foods Shares Are Trading Lower By Around 25%? Here Are Other Stocks Moving In Tuesday's Mid-Day SessionMarch 4, 2024 | finance.yahoo.comAclarion Announces Publication of Compelling Peer-Reviewed Data in International Journal of Spine Surgery Supporting Nociscan as a Gold Standard for Noninvasive Identification of Painful Lumbar DiscsFebruary 27, 2024 | globenewswire.comAclarion Announces Closing of $3.0 Million Public OfferingFebruary 26, 2024 | msn.comWhy Aclarion (ACON) Shares Are Down Over 60% TodayFebruary 26, 2024 | globenewswire.comAclarion Announces Pricing of $3.0 Million Public OfferingFebruary 26, 2024 | investorplace.comWhy Is Aclarion (ACON) Stock Down 19% Today?February 26, 2024 | investorplace.comWhy Is Aclarion (ACON) Stock Down 19% Today?February 1, 2024 | benzinga.comAclarion Stock (NASDAQ:ACON), Short Interest ReportJanuary 30, 2024 | benzinga.comAclarion Stock (NASDAQ:ACON) Dividends: History, Yield and DatesJanuary 22, 2024 | markets.businessinsider.comEQS-News: Aclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MDJanuary 22, 2024 | markets.businessinsider.comAclarion Expands Nociscan Access Into Phoenix With Key Opinion Leader Surgeon Advisor Juan Uribe, MDJanuary 8, 2024 | marketbeat.comTrading was temporarily halted for "ACON" at 09:01 AM with a stated reason of "LULD pause."January 5, 2024 | marketbeat.comTrading was temporarily halted for "ACON" at 11:01 AM with a stated reason of "LULD pause."January 4, 2024 | marketbeat.comTrading was temporarily halted for "ACON" at 10:01 AM with a stated reason of "LULD pause."January 4, 2024 | marketbeat.comTrading was temporarily halted for "ACON" at 10:01 AM with a stated reason of "LULD pause."January 4, 2024 | marketbeat.comTrading was temporarily halted for "ACON" at 09:01 AM with a stated reason of "LULD pause."January 4, 2024 | marketbeat.comTrading was temporarily halted for "ACON" at 07:01 PM with a stated reason of "News pending."January 3, 2024 | ca.finance.yahoo.comACLARION INC. DL-,00001 (IT2.BE)January 2, 2024 | finance.yahoo.comAclarion Announces Reverse Stock SplitNovember 27, 2023 | finance.yahoo.comAclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan ExamsNovember 9, 2023 | finance.yahoo.comAclarion Announces Achievement of Goal to Enroll 10 Leading Spine Surgery Key Opinion Leaders (KOLs) to Support Nociscan AdoptionNovember 6, 2023 | markets.businessinsider.comAclarion Expands Immediate Nociscan Access Into New York City With Tenth Key Opinion Leader Surgeon Advisor Addition Roger Hartl, MDOctober 25, 2023 | finance.yahoo.comAclarion Announces Signing of Commercial Agreement With Porter Hospital, an AdventHealth facility, to Bring Nociscan Technology to DenverOctober 24, 2023 | finance.yahoo.comAclarion Announces Nociscan® Cost-Effectiveness Poster Presented at 45th Annual SMDM MeetingOctober 2, 2023 | finance.yahoo.comAclarion Provides Updated Investor Presentation and Corporate UpdateSeptember 8, 2023 | barrons.comAclarion Inc.August 25, 2023 | finance.yahoo.comAclarion, Inc. Announces Filing of Delayed 10-Q Quarterly ReportJune 14, 2023 | finance.yahoo.comAclarion Announces New Commercial Engagement with The Imaging Center, Grand Rapids, MIJune 8, 2023 | benzinga.comWhy Aclarion Stock Is Popping TodayJune 8, 2023 | msn.comACON Skyrockets after Presentation of Nociscan AbstractJune 8, 2023 | finance.yahoo.comAclarion Announces Statistically Significant Nociscan® Cost-Effectiveness Abstract Presented at ISASS Annual MeetingMay 30, 2023 | finance.yahoo.comAclarion Announces New Engagement with The London Clinic and London Spine ClinicMay 23, 2023 | finance.yahoo.comAclarion, Inc. Announces Delayed 10-Q FilingMay 23, 2023 | finance.yahoo.comAclarion’s Key Opinion Leader Program Adds Ninth Surgeon Advisor With Addition of Dean Karahalios, MDMay 19, 2023 | msn.comAclarion gets $2M debt financingMay 19, 2023 | finance.yahoo.comAclarion Announces Non-Convertible Debt Financing to Achieve Three Critical CatalystsMay 10, 2023 | proactiveinvestors.comAclarion providing less invasive solution to treat lo back pain through augmented intelligenceApril 28, 2023 | finance.yahoo.comAclarion to Host Thought Leadership Symposium at SPINEWEEK 2023April 24, 2023 | ca.finance.yahoo.comAclarion, Inc. (ACON) Interactive Stock Chart - Yahoo FinanceApril 24, 2023 | marketbeat.comTrading was temporarily halted for "ACON" at 03:04 PM with a stated reason of "LULD pause."April 24, 2023 | marketbeat.comTrading was temporarily halted for "ACON" at 12:04 PM with a stated reason of "LULD pause." Get Aclarion News Delivered to You Automatically Sign up to receive the latest news and ratings for ACON and its competitors with MarketBeat's FREE daily newsletter. Email Address “Generational Bull Run” Incoming (Ad)LIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 special FREE Gifts during the event. You can find out what they are by clicking here now. ACON Media Mentions By Week ACON Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. ACON News Sentiment▼0.660.61▲Average Medical News Sentiment ACON News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. ACON Articles This Week▼40▲ACON Articles Average Week Get Aclarion News Delivered to You Automatically Sign up to receive the latest news and ratings for ACON and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: Agape ATP News Today NewGenIvf Group News Today DermTech News Today Better Therapeutics News Today American Oncology Network News Today Concord Medical Services News Today Global Cord Blood News Today Natera News Today Fresenius Medical Care News Today Option Care Health News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:ACON) was last updated on 7/27/2024 by MarketBeat.com Staff From Our Partners625,000% GainImagine swapping your daily coffee expense for a future free of financial worries. It might seem far-fetche...Crypto Swap Profits | Sponsored“Generational Bull Run” IncomingLIVE Cash Flow Workshop Event / Hosted Virtually Weds @ 7PM EST Everyone who attends will also receive 3 sp...Unstoppable Prosperity | SponsoredRare signal predicts 50% market drop - before electionThe market is near all-time highs, we're told that unemployment is low, AI's a gift to humanity, and the FED w...Behind the Markets | SponsoredThis student turned $1,300 into $45,000 in just 4 Months!With the help of S.A.M. (my new AI-powered scanner) it's now easier than ever to find these unique trades... ...Monument Traders Alliance | SponsoredCollapse of the PetrodollarThe death of the "petrodollar" seems imminent. And the implications could not be worse for Americans. Ru...Colonial Metals | SponsoredFormer Hedge Fund Manager Issues Crash PredictionOur No. 1 stock for the rare "millionaire window" opening NOW According to Wall Street legend Whitney Tilso...Stansberry Research | SponsoredBrace Yourself: Experts calling for Bitcoin to hit $100kFor the past few months, Bitcoin has been trading flat… It's been stuck around the $60,000 to $72,000 range...Crypto 101 Media | SponsoredBreaking News: Elon Musk Invents New Type of A.I. (Shocking)Could Elon's New Device be Bigger than the iPhone? According to 30-year Silicon Valley and Wall Street vete...InvestorPlace | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Aclarion, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Aclarion With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
